The allowance of a patent application is a significant positive development for Cyclo Therapeutics, as it strengthens the company's intellectual property rights. This can lead to increased investor confidence, as patents are critical in protecting the commercial potential of new treatments. It may also attract potential partnerships or additional funding, as companies with strong patent portfolios are often seen as more attractive investments. The news is directly related to CYTH and is likely to have a positive impact on the stock price in the short term.